Micro-costing studies in the health and medical literature: Protocol for a systematic review

Systematic Reviews

Volumn 3, Issue 1, 2014, Pages

  Xu, Xiao ^a   Nardini, Holly K Grossetta ^a   Ruger, Jennifer Prah ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cost analysis; Economic evaluation; Health; Micro costing; Systematic review

Indexed keywords

ARTICLE; CHECKLIST; COST BENEFIT ANALYSIS; DECISION MAKING; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; MICRO COSTING; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW (TOPIC); HEALTH SERVICES RESEARCH; METHODOLOGY; REVIEW; STANDARD; STATISTICS;

COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HUMANS;

EID: 84907275718     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-3-47     Document Type: Article

References (24)

1. Gold MR, Siegel JE, Russell LB, Weinstein MC: Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
2. Tan SS, Rutten FF, van Ineveld BM, Redekop WK, Hakkaart-van Roijen L: Comparing methodologies for the cost estimation of hospital services. Eur J Health Econ 2009, 10:39-45.
3. Heerey A, McGowan B, Ryan M, Barry M: Microcosting versus DRGs in the provision of cost estimates for use in pharmacoeconomic evaluation. Expert Rev Pharmacoecon Outcomes Res 2002, 2:29-33.
4. Clement Nee Shrive FM, Ghali WA, Donaldson C, Manns BJ: The impact of using different costing methods on the results of an economic evaluation of cardiac care: microcosting vs gross-costing approaches. Health Econ 2009, 18:377-388.
5. Ruger JP, Emmons KM, Kearney MH, Weinstein MC: Measuring the costs of outreach motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women. BMC Pregnancy Childbirth 2009, 9:46.
6. Barnett PG: An improved set of standards for finding cost for cost-effectiveness analysis. Med Care 2009, 47:S82-S88.
7. Frick KD: Microcosting quantity data collection methods. Med Care 2009, 47:S76-S81.
8. Moher D, Liberati A, TetzlaffJ, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535.
9. Shemilt I, Mugford M, Byford S, Drummond M, Eisenstein E, Knapp M, Mallender J, McDaid D, Vale L, Walker D: Chapter 15: Incorporating economics evidence. In Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. (updated March 2011). Edited by Higgins JPT, Green S. Oxford, UK: The Cochrane Collaboration; 2011. Available from www.cochrane-handbook.org.
10. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, Porter AC, Tugwell P, Moher D, Bouter LM: Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007, 7:10.
11. Xu X, Lazar C, Grossetta Nardini HK, Ruger JP: Micro-costing studies in the health and medical literature: a systematic review. PROSPERO; 2014. CRD42014007453 Available from http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014007453.
12. AcademyHealth: Health Economics Core Library Recommendations, 2011. Bethesda, MD: Funded by the U.S. National Library of Medicine; 2011. Available from http://www.nlm.nih.gov/nichsr/corelib/hecon-2011.html.
13. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E: Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health 2013, 16:231-250.
14. Ruger JP, Emmons KM: Economic evaluations of smoking cessation and relapse prevention programs for pregnant women: a systematic review. Value Health 2008, 11:180-190.
15. Ruger JP, Lazar CM: Economic evaluation of drug abuse treatment and HIV prevention programs in pregnant women: a systematic review. Addict Behav 2012, 37:1-10.
16. Ruger JP, Lazar CM: Economic evaluation of pharmaco-and behavioral therapies for smoking cessation: a critical and systematic review of empirical research. Annu Rev Public Health 2012, 33:279-305.
17. Ruger JP, Ben Abdallah A, Cottler L: Costs of HIV prevention among outof-treatment drug-using women: results of a randomized controlled trial. Public Health Rep 2010, 125(Suppl 1):83-94.
18. Ruger JP, Chawarski M, Mazlan M, Luekens C, Ng N, Schottenfeld R: Costs of addressing heroin addiction in Malaysia and 32 comparable countries worldwide. Health Serv Res 2012, 47:865-887.
19. Drummond MF, Jefferson TO: Guidelines for authors and peer reviewers of economic submissions to the BMJ: the BMJ economic evaluation working party. BMJ 1996, 313:275-283.
20. Evers S, Goossens M, de Vet H, van Tulder M, Ament A: Criteria list for assessment of methodological quality of economic evaluations: consensus on health economic criteria. Int J Technol Assess Health Care 2005, 21:240-245.
21. Philips Z, Bojke L, Sculpher M, Claxton K, Golder S: Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment. Pharmacoeconomics 2006, 24:355-371.
22. Walker DG, Wilson RF, Sharma R, Bridges J, Niessen L, Bass EB, Frick K: Best Practices for Conducting Economic Evaluations in Health Care: A Systematic Review of Quality Assessment Tools. Rockville, MD: Agency for Healthcare Research and Quality; 2012.
23. Fukuda H, Imanaka Y: Assessment of transparency of cost estimates in economic evaluations of patient safety programmes. J Eval Clin Pract 2009, 15:451-459.
24. Bell CM, Urbach DR, Ray JG, Bayoumi A, Rosen AB, Greenberg D, Neumann PJ: Bias in published cost effectiveness studies: systematic review. BMJ 2006, 332:699-703.